# Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: Developing Drug and Biological Products in Oncology - FDA Guidance Document Source: https://www.globalkeysolutions.net/guidances/guidance-document/prevention-and-treatment-of-chemotherapy-induced-peripheral-neuropathy-developing-drug-and-biological-products-in-oncology/21c15304-ad79-4fb0-8609-1712f3c9952b > FDA guidance document: Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: Developing Drug and Biological Products in Oncology. Issue date: January 17, 2025. Get complete insights and analysis. --- ## Details - Title: Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: Developing Drug and Biological Products in Oncology - Communication Type: Guidance Document - Product Type: biologics - Office Name: Office of the Commissioner - Office URL: /offices/office-of-the-commissioner/79483979-9582-427f-ac3d-46c715811424 - Issue Date: 2025-01-17 - Comment Close Date: 2025-03-18 - Last Changed: 2025-01-16 - Docket Number: FDA-2024-D-5663 ## Related Documents - [Early Alzheimer’s Disease: Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/early-alzheimers-disease-developing-drugs-for-treatment/ef0ff9a7-7208-4951-acbb-acb9937f83e7) - [Acute Myeloid Leukemia: Developing Drugs and Biological Products for Treatment: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/acute-myeloid-leukemia-developing-drugs-and-biological-products-for-treatment-draft-guidance-for-industry/8143a606-18fc-488c-b3ab-4c23bdcd999a) - [Setting Endotoxin Limits During Development of Investigational Oncology Drugs and Biological Products Guidance for Industry: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/setting-endotoxin-limits-during-development-of-investigational-oncology-drugs-and-biological-products-guidance-for-industry-draft-guidance-for-industry/ef751a3a-e9d6-4489-b86d-73f2411682c1)